ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease

Song, Xuewen; Tsakiridis, Evelyn; Steinberg, Gregory R.; Pei, York*
Cellular Signalling2020-9DOI: 10.1016/j.cellsig.2020.109704
23被引1阅读
引用收藏
分享

摘要

Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenetic kidney disease worldwide and an important cause of chronic kidney disease. Multiple experimental studies have highlighted the role of increased mammalian target of rapamycin complex 1 (mTORC1) and reduced AMP-activated protein kinase (AMPK) signaling in modulating cyst growth in ADPKD. Notably, mTORC1 and AMPK are two diametrically opposing sensors of energy metabolism which regulate cell growth and proliferation. Although pharmacological mTORC1 inhibition was highly effective in experimental studies of ADPKD, clinical trials of mTORC1 inhibitors showed a lack of efficacy with low-dose treatment and poor tolerability with high-dose treatment. Therapeutic AMPK activation has been shown to attenuate cystic kidney disease severity in Pkd1 mutant animal models by improving mitochondrial biogenesis and reducing tissue inflammation. This review summarizes the current knowledge on the function of AMPK as a regulator of cellular energy metabolism and how AMPK activation by pharmacological and non-pharmacological means can potentially be exploited to treat ADPKD in the clinical settings.

学科与关键词

关键词
Polycystic kidney diseasemTORC1AMPKEnergy metabolismInflammation
相关
加载中…
  • AMPK Activator O304 Protects Against Kidney Aging Through Promoting Energy Metabolism and Autophagy
    Zhu, Mingsheng; Shen, Weiwei; Li, Jiemei; Jia, Nan; Xiong, Yabing; Miao, Jinhua; Xie, Chao; Chen, Qiyan; Shen, Kunyu; Meng, Ping; Li, Xiaolong; Wu, Qinyu; Zhou, Shan; Wang, Maosheng*; Kong, Yaozhong*; Zhou, Lili*Frontiers in Pharmacology, 2022, 13: 836496.被引 9
  • Up-regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease
    Jennifer Q.J. Zhang; Sayanthooran Saravanabavan; Ashley N. Chandra; Alexandra Munt; Annette T.Y. Wong; Peter C. Harris; David C.H. Harris; Paul McKenzie; Yiping Wang; Gopala K. Rangan*American Journal of Pathology, 2021, 106005.
  • CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY
    Huang, Yuliang; Chen, Junzhe; Shao, Xiaofei; Li, Jinxiang; Tang, Ying60th ERA Congress, Milan, ITALY, 2023-06-15 To 2023-06-18.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cellular Signalling
发表日期
2020-09
卷期
第 73 卷
页码
109704
DOI
10.1016/j.cellsig.2020.109704
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE
资助标注
Canadian Institutes of Health Research (CIHR)Strategy for Patient Oriented Research (SPOR) Program grant in Chronic Kidney Disease [CAN-Solve-CKD SCA-145103]; CIHR Foundation [201709FDN-CEBA-116200]; Diabetes Canada Investigator Award [DI-5-17-5302-GS]; Tier 1 Canada Research Chair; J Bruce Duncan Endowed Chair in Metabolic Diseases

作者

  • S

    Song, Xuewen (第一作者)

  • T

    Tsakiridis, Evelyn

查看全部 4 位作者收起作者
  • S

    Steinberg, Gregory R.

  • P

    Pei, York (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417